Fundraising Fox

Genialis

Boston, US · Delaware corporation · 6 known investors

genialis.com ↗

Genialis develops artificial intelligence models trained on ethnically diverse cancer datasets to predict patient responses to targeted therapies and immunotherapies, supporting treatment decisions for pharmaceutical and diagnostic companies.

AI & Machine LearningBiotechMedical Devicesin /genialis

Founders & leadership

IL
Ita LuDirector
CH
Cedric Hermann OdjeDirector
ES
Elia StupkaDirector
KM
Krista McKerracherDirector
MŠ
Miha ŠtajdoharExecutive Officer, Director
RR
Rafael RosengartenChief Executive Officer and Co-founder
LA
Luka AusecExecutive Officer
NG
Nadine GeiserDirector
HA
Hamzeh Abdul-HadiDirector
DV
Drew VolpeDirector
TK
Tjasa Krisper KutinExecutive Officer

Investors · 6

Angelini Ventures✓ verifiedRome
Taiwania Capital✓ verifiedTaipei · $3M – $85M
Debiopharm Innovation FundLausanne · $1M – $5M
First Star VenturesCambridge · $100K – $1Mvia Drew Volpe · board
ScaleX VenturesAmsterdam · $216K – $2.2M
redalpinereportedZug · $108K – $2.2M

Reported raises · per SEC filings

Form D private placements
▶$700KraisedDec 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ita LuDirector
  • Cedric Hermann OdjeDirector
  • Elia StupkaDirector
  • Krista McKerracherDirector
  • Miha StajdoharExecutive Officer, Director
  • Rafael RosengartenExecutive Officer, Director
  • Luka AusecExecutive Officer
Offering amount
$3M
Amount sold
$700K
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.4MraisedJan 2023 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nadine GeiserDirector
  • Elia StupkaDirector
  • Ita LuDirector
  • Luka AusecExecutive Officer
  • Rafael RosengartenExecutive Officer, Director
  • Hamzeh Abdul-HadiDirector
  • Drew VolpeDirector
  • Miha StajdoharExecutive Officer, Director
  • Tjasa Krisper KutinExecutive Officer
Offering amount
$13.9M
Amount sold
$11.4M
Proceeds to insiders
$1.4M
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.